Merete Lund Hetland
Summary of the talk: DANBIO is a nationwide Danish quality registry aiming at improving the quality of treatment of patients with inflammatory arthritis. With high completeness and the potential to enrich data with data from other national databases, it is possible to do high-quality epidemiologic studies. In addition, the DANBIO platform is also used as eCRF for investigator-initiated trials. The lecture will include a brief presentation of DANBIO, followed by an overview of some of the recent clinical and registry studies that have been conducted based on DANBIO. This includes studies on rheumatoid arthritis e.g. tapering of biologics, how to reduce sedate lifestyle and use of biosimilars.
Short biography: Professor Merete Lund Hetland is a professor at University of Copenhagen, Denmark, and a consultant at the Department of Rheumatology, Rigshospitalet, Glostrup, Denmark. Merete Hetland obtained her MD from the University of Copenhagen in 1988, and became a specialist in rheumatology in 2000. She received her PhD on the bone metabolism in male and female runners in 1997, and her DMSc in modern treatment strategies in rheumatoid arthritis in 2011, both at the University of Copenhagen. Professor Hetland is a reviewer for multiple peer-reviewed journals in rheumatology and since 2009 an abstract reviewer for EULAR and ACR. Since 2000, she has been responsible for the Danish nationwide clinical register for patients with rheumatoid arthritis (DANIBIO) and since 2015 for the nationwide Danish Rheumatologic Biobank. Merete Hetland’s current research focus is on inflammatory joint diseases, treatment strategies, predictors, RCT and observational studies. Over the years, Merete Hetland has worked as a personal investigator in multiple clinical trials of rheumatoid arthritis. She has delivered a variety of publications, including 194 manuscripts, eight book chapters and >300 abstracts, as well as given more than >120 lectures at national and international congresses and meetings.